TWi Biotechnology (ROCO:6610) Total Equity: NT$630.44 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6610 TWi Biotechnology Inc ROCO:6610
34 GF Score
Price NT$27.20
! 2 Warning Signs
View Full Analysis

What is TWi Biotechnology Total Equity?

TWi Biotechnology ROCO:6610 +0.37% 34 Total Equity is NT$630.44 Mil as of Dec. 2025. GuruFocus rates ROCO:6610 with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

TWi Biotechnology's total equity for the quarter that ended in Dec. 2025 was NT$630.44 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

TWi Biotechnology Total Equity Historical Data

* Premium members only.

The historical data trend for TWi Biotechnology's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TWi Biotechnology Total Equity Chart

TWi Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 278.80 205.92 341.04 807.96 630.44

TWi Biotechnology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 341.04 243.65 807.96 268.86 630.44
ROCO:6610
34GF Score
TWi Biotechnology Inc ROCO:6610
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TWi Biotechnology Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

TWi Biotechnology's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=723.576-93.138
=630.44

TWi Biotechnology's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=723.576-93.138
=630.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$630.44 Mil mean?
TWi Biotechnology (ROCO:6610) has a Total Equity of NT$630.44 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for TWi Biotechnology and its competitors.
Is TWi Biotechnology's Total Equity too high?
TWi Biotechnology's current Total Equity is NT$630.44 Mil. Overall, TWi Biotechnology has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does TWi Biotechnology's Total Equity compare to VRTX and REGN?
TWi Biotechnology's Total Equity of NT$630.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for TWi Biotechnology and its competitors. TWi Biotechnology's current Total Equity is NT$630.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TWi Biotechnology stock overvalued right now?
TWi Biotechnology (ROCO:6610) has a current Total Equity of NT$630.44 Mil. The current Total Equity is NT$630.44 Mil. TWi Biotechnology's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For TWi Biotechnology (ROCO:6610), the current Total Equity is NT$630.44 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TWi Biotechnology Business Description

Address Lane 221, Kang Chien Road, 8th Floor, Number 41, Neihu District, Taipei, TWN, 11494
TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.
34GF Score

Get the complete analysis for ROCO:6610

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$27.20
Price